文献速递糖尿病

伴非自身免疫特征的糖尿病儿童应考虑单基因糖尿病检测

Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

研究纳入183例伴至少一种非自身免疫性胰腺外特征的糖尿病儿童,33%(61/183)确诊单基因糖尿病,其中84%为隐性病因,WFS1变异最常见(46%)。低T1D遗传风险评分且抗体阴性/未检测者单基因糖尿病比例显著更高,提示抗体和T1DGRS有助于优先安排基因检测。

要点

  • 伴非自身免疫性胰腺外特征的糖尿病儿童中33%确诊单基因糖尿病。
  • 单基因病例中84%为隐性病因,WFS1变异占46%。
  • 低T1DGRS且抗体阴性/未检测者单基因糖尿病比例达48%。

核心结论

  • 伴至少一种非自身免疫性胰腺外特征的糖尿病儿童应考虑进行单基因糖尿病基因检测。
  • 胰岛自身抗体和1型糖尿病遗传风险评分有助于确定基因检测的优先顺序。

研究设计与样本

  • 招募183例糖尿病且伴至少一种非自身免疫性胰腺外特征的儿童,50%(n=91)自报近亲婚配。
  • 检测胰岛自身抗体和1型糖尿病遗传风险评分(T1DGRS),并使用靶向二代测序分析所有已知单基因糖尿病病因。

主要发现

  • 33%(61/183)的儿童确诊单基因糖尿病。
  • 单基因糖尿病病例中84%(51/61)为隐性病因,WFS1变异占46%、SLC19A2变异占12%、SLC29A3变异占12%。
  • 单基因病例与非单基因病例的诊断年龄(7.4 vs 6,P=.1)和BMI z评分(-0.08 vs -0.41,P=.3)相似。
  • 单基因病例的父母近亲婚配比例更高(62% vs 19%,P=.01),多器官系统特征比例更高(53% vs 28%,P=.01)。
  • 仅59%报告了与其相关遗传综合征的公认特征。

关键数值与推荐

  • 低T1DGRS(<T1D人群第50百分位)且抗体阴性/未检测者单基因病因比例为48%,抗体阳性者为3%,抗体阴性/未检测且高T1DGRS(≥第50百分位)者为7%(P<.0001)。

临床怎么用

  • 对伴至少一种非自身免疫性胰腺外特征的糖尿病儿童,应启动单基因糖尿病检测评估。
  • 检测胰岛自身抗体和T1DGRS,低T1DGRS且抗体阴性/未检测者应优先进行基因检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Monogenic diabetes testing in children currently targets maturity onset diabetes in the young (MODY) or recognized genetic syndromes. OBJECTIVE: We aim to determine whether genetic testing for monogenic diabetes should be performed for all children with diabetes and at least one non-autoimmune extra-pancreatic feature (syndromic diabetes). METHODS: We recruited 183 children with diabetes and at least one non-autoimmune extra-pancreatic feature (50% [n = 91] with self-reported consanguinity). We measured islet-autoantibodies and type 1 diabetes (T1D) genetic risk score (T1DGRS) and used targeted next-generation sequencing to analyze all known causes of monogenic diabetes. RESULTS: Of the children, 33% (61/183) had confirmed monogenic diabetes. Of these, 84% (51/61) had recessive etiologies with variants in WFS1 (46%), SLC19A2 (12%) and SLC29A3 (12%) being most common. Monogenic cases compared to non-monogenic had similar age of diagnosis (7.4 vs 6, P = .1) and body mass index z-score (-0.08 vs -0.41, P = .3) but had higher parental consanguinity (62% vs 19%, P = .01) and features in multiple organ systems (53% vs 28%, P = .01). Only 59% reported well-recognized features of their associated genetic syndrome. Children with low T1DGRS (<50th centile of T1D population) and negative/untested antibodies were more likely to have monogenic cause compared to positive antibodies or negative/untested antibodies and a high T1DGRS (≥ 50th centile) (48% vs 3% vs 7%, P < .0001). CONCLUSION: Children with diabetes and at least one non-autoimmune extra-pancreatic feature should be considered for monogenic diabetes testing. Measurement of islet-autoantibodies and T1DGRS help prioritize genetic testing.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Myers R, Yildiz M, Nuri Ozbek M, et al. Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing. J Clin Endocrinol Metab. 2026. PMID: 40746173. doi:10.1210/clinem/dgaf430

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。